Gynaecological cancer in Caribbean women: data from the French population-based cancer registries of Martinique, Guadeloupe and French Guiana (2007-2014).
Cancer registry
Caribbean
Incidence
Women
Journal
BMC cancer
ISSN: 1471-2407
Titre abrégé: BMC Cancer
Pays: England
ID NLM: 100967800
Informations de publication
Date de publication:
10 Jul 2020
10 Jul 2020
Historique:
received:
27
11
2019
accepted:
02
07
2020
entrez:
12
7
2020
pubmed:
12
7
2020
medline:
11
3
2021
Statut:
epublish
Résumé
For the first time, we present regional-level cancer incidence and world-standardized mortality rates for cancers for Martinique, Guadeloupe and French Guiana. For Martinique, Guadeloupe and French Guiana, incidence data come from population-based cancer registries, and cover the periods 2007-2014, 2008-2014 and 2010-2014 respectively. Standardized incidence and mortality rates were calculated using the world population. In the 3 regions, all cancers combined represent 3567 new cases per year, of which 39.8% occur in women, and 1517 deaths per year (43.4% in women). Guadeloupe and Martinique present similar world-standardized incidence rates. Among gynaecological cancers, breast cancer, the second most common cancer type in the 3 regions, has an incidence rate 35 to 46% lower than in mainland France. On the other hand, cervical cancer has a higher incidence rate, particularly in French Guiana. For both endometrial cancer and ovarian cancer, no significant differences in incidence rates are found compared to mainland France. Regarding mortality, world-standardized mortality rates are similar between Guadeloupe and Martinique, and higher than in French Guiana. This situation compares favourably with mainland France (all cancers). Among gynaecological cancers, the mortality rate is lower for breast cancer in all regions compared to mainland France, and also lower for ovarian cancer in Martinique and Guadeloupe, but higher (albeit non-significantly) in French Guiana. The ethno-geographic and socio-demographic characteristics in this population of mainly Afro-Caribbean origin could partially explain these disparities. Major disparities exist for certain cancer sites: excess incidence and excess mortality for cervical cancer; lower, but increasing incidence of breast cancer.
Sections du résumé
BACKGROUND
BACKGROUND
For the first time, we present regional-level cancer incidence and world-standardized mortality rates for cancers for Martinique, Guadeloupe and French Guiana.
METHODS
METHODS
For Martinique, Guadeloupe and French Guiana, incidence data come from population-based cancer registries, and cover the periods 2007-2014, 2008-2014 and 2010-2014 respectively. Standardized incidence and mortality rates were calculated using the world population.
RESULTS
RESULTS
In the 3 regions, all cancers combined represent 3567 new cases per year, of which 39.8% occur in women, and 1517 deaths per year (43.4% in women). Guadeloupe and Martinique present similar world-standardized incidence rates. Among gynaecological cancers, breast cancer, the second most common cancer type in the 3 regions, has an incidence rate 35 to 46% lower than in mainland France. On the other hand, cervical cancer has a higher incidence rate, particularly in French Guiana. For both endometrial cancer and ovarian cancer, no significant differences in incidence rates are found compared to mainland France. Regarding mortality, world-standardized mortality rates are similar between Guadeloupe and Martinique, and higher than in French Guiana. This situation compares favourably with mainland France (all cancers). Among gynaecological cancers, the mortality rate is lower for breast cancer in all regions compared to mainland France, and also lower for ovarian cancer in Martinique and Guadeloupe, but higher (albeit non-significantly) in French Guiana.
CONCLUSION
CONCLUSIONS
The ethno-geographic and socio-demographic characteristics in this population of mainly Afro-Caribbean origin could partially explain these disparities. Major disparities exist for certain cancer sites: excess incidence and excess mortality for cervical cancer; lower, but increasing incidence of breast cancer.
Identifiants
pubmed: 32650744
doi: 10.1186/s12885-020-07128-1
pii: 10.1186/s12885-020-07128-1
pmc: PMC7350571
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
643Subventions
Organisme : Sante publique france
ID : -
Organisme : INCa
ID : -
Références
Int J Gynaecol Obstet. 2014 May;125(2):166-7
pubmed: 24598347
Eur J Epidemiol. 2015 May;30(5):397-412
pubmed: 25800123
Euro Surveill. 2016 Jul 14;21(28):
pubmed: 27447300
Lancet. 2007 Sep 8;370(9590):890-907
pubmed: 17826171
Cancer Causes Control. 2017 Nov;28(11):1305-1312
pubmed: 28849411
Rev Epidemiol Sante Publique. 2014 Apr;62(2):95-108
pubmed: 24613140
Nephrol Ther. 2018 Nov;14(6):467-473
pubmed: 29477278
Gynecol Oncol. 2015 Nov;139(2):324-9
pubmed: 26383829
Acta Obstet Gynecol Scand. 2004 Sep;83(9):783-95
pubmed: 15315588
Front Oncol. 2016 Apr 14;6:89
pubmed: 27148481
Int J Cancer. 2015 Mar 1;136(5):E359-86
pubmed: 25220842
Epidemiol Infect. 2017 Apr;145(6):1276-1284
pubmed: 28091335
Int J Stroke. 2017 Oct;12(8):844-850
pubmed: 28043214
J Hum Reprod Sci. 2015 Jan-Mar;8(1):3-13
pubmed: 25838742
Breast Cancer Res Treat. 2014 Aug;147(1):167-75
pubmed: 25106658
Glob Health Action. 2017;10(1):1337341
pubmed: 28649938
BMC Womens Health. 2018 Jan 24;18(1):25
pubmed: 29368607
Stroke. 2010 Apr;41(4):594-9
pubmed: 20167913
Am J Epidemiol. 2017 Nov 15;186(10):1194-1203
pubmed: 28200111
BMC Public Health. 2019 Oct 30;19(1):1424
pubmed: 31666052
Int J Gynecol Cancer. 2012 Jun;22(5):850-3
pubmed: 22635032
Ann Cardiol Angeiol (Paris). 2014 Jun;63(3):155-62
pubmed: 24958528
Biostatistics. 2019 Jul 1;20(3):452-467
pubmed: 29617897
Women Health. 2018 Feb;58(2):145-159
pubmed: 28095137
Am Soc Clin Oncol Educ Book. 2018 May 23;38:451-456
pubmed: 30231404
Int J Equity Health. 2017 Apr 5;16(1):60
pubmed: 28381227
Springerplus. 2013 Sep 17;2:471
pubmed: 24083115
Eur J Cancer Prev. 2018 Sep;27(5):486-492
pubmed: 28362653
Cancer Causes Control. 2014 Apr;25(4):479-89
pubmed: 24487725
Cancer Prev Res (Phila). 2017 Jan;10(1):1-13
pubmed: 27965288
Clin Genet. 2014 Jan;85(1):64-7
pubmed: 23458327
Ann Cardiol Angeiol (Paris). 2019 Oct;68(4):260-263
pubmed: 31563267
Cancer Biol Med. 2017 Feb;14(1):9-32
pubmed: 28443200
Clin Breast Cancer. 2016 Aug;16(4):e113-8
pubmed: 27036361
Am J Hum Genet. 2003 May;72(5):1117-30
pubmed: 12677558
Am J Epidemiol. 2019 Jul 1;188(7):1389-1396
pubmed: 30995296
BMC Public Health. 2017 Mar 24;17(1):279
pubmed: 28340612
Cancer Epidemiol. 2017 Oct;50(Pt B):268-271
pubmed: 29120835
Vaccine. 2012 Nov 20;30 Suppl 5:F12-23
pubmed: 23199955